Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Price Crosses Above 50 Day Moving Average of $8.04

Shares of Bavarian Nordic A/S (OTCMKTS:BVNRY) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $8.04 and traded as high as $8.23. Bavarian Nordic A/S shares last traded at $8.23, with a volume of 2,203 shares changing hands.

Bavarian Nordic A/S Stock Performance

The company has a market capitalization of $1.98 billion, a P/E ratio of 13.38 and a beta of 1.67. The firm has a 50 day moving average price of $8.08 and a two-hundred day moving average price of $7.92.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last released its quarterly earnings results on Wednesday, May 8th. The company reported ($0.07) EPS for the quarter. The business had revenue of $121.08 million for the quarter. Bavarian Nordic A/S had a return on equity of 15.54% and a net margin of 14.74%. On average, equities analysts expect that Bavarian Nordic A/S will post 0.52 earnings per share for the current year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.